$EXEL
EXELIXIS, INC.

2016 Q4 Form 10-K Financial Statement

#000093976717000019 Filed on February 27, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q1 2015 Q4
Revenue $77.58M $15.43M $9.938M
YoY Change 680.65% 64.33% 35.16%
Cost Of Revenue $1.900M $685.0K $1.000M
YoY Change 90.0% -10.57% 42.86%
Gross Profit $50.06M $8.414M $8.915M
YoY Change 461.57% -2.41% 33.68%
Gross Profit Margin 64.53% 54.54% 89.71%
Selling, General & Admin $13.00M $34.86M $17.10M
YoY Change -23.98% 265.72% 74.49%
% of Gross Profit 25.97% 414.27% 191.81%
Research & Development $23.80M $28.93M $23.50M
YoY Change 1.28% 29.82% -40.81%
% of Gross Profit 47.54% 343.78% 263.6%
Depreciation & Amortization $200.0K $229.0K $300.0K
YoY Change -33.33% -22.9% -150.0%
% of Gross Profit 0.4% 2.72% 3.37%
Operating Expenses $36.70M $64.56M $40.60M
YoY Change -9.61% 100.83% -17.81%
Operating Profit $38.88M -$49.14M -$31.60M
YoY Change -223.05% 115.88% -31.61%
Interest Expense -$3.600M $10.29M -$9.900M
YoY Change -63.64% -17.04% -16.81%
% of Operating Profit -9.26%
Other Income/Expense, Net -$10.09M
YoY Change -18.71%
Pretax Income $35.10M -$59.22M -$41.50M
YoY Change -184.58% 68.25% -28.57%
Income Tax $0.00 $100.0K
% Of Pretax Income
Net Earnings $35.12M -$59.22M -$41.57M
YoY Change -184.5% 78.14% -28.27%
Net Earnings / Revenue 45.27% -383.89% -418.27%
Basic Earnings Per Share $0.12 -$0.26
Diluted Earnings Per Share $0.12 -$0.26 -$182.9K
COMMON SHARES
Basic Shares Outstanding 286.5M shares 228.3M shares 227.2M shares
Diluted Shares Outstanding 228.3M shares

Balance Sheet

Concept 2016 Q4 2016 Q1 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $419.8M $322.1M $167.1M
YoY Change 151.23% 200.47% 15.8%
Cash & Equivalents $151.7M $141.6M $141.6M
Short-Term Investments $268.1M $45.20M $25.40M
Other Short-Term Assets $5.400M $4.800M $3.800M
YoY Change 42.11% -57.52% -75.8%
Inventory $3.338M $2.472M $2.616M
Prepaid Expenses
Receivables $40.40M $10.10M $5.200M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $469.0M $339.5M $178.7M
YoY Change 162.5% 171.49% 6.83%
LONG-TERM ASSETS
Property, Plant & Equipment $2.071M $1.813M $1.434M
YoY Change 44.42% -15.99% -41.04%
Goodwill $63.68M $63.68M $63.68M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $55.60M $82.90M $83.60M
YoY Change -33.49% 1.59% 2.45%
Other Assets $1.232M $2.068M $2.309M
YoY Change -46.64% -73.39% -36.72%
Total Long-Term Assets $126.7M $153.1M $153.7M
YoY Change -17.53% -3.06% -1.51%
TOTAL ASSETS
Total Short-Term Assets $469.0M $339.5M $178.7M
Total Long-Term Assets $126.7M $153.1M $153.7M
Total Assets $595.7M $492.5M $332.3M
YoY Change 79.25% 74.08% 2.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.565M $5.657M $6.401M
YoY Change 2.56% 334.15% -0.19%
Accrued Expenses $53.40M $16.14M $18.07M
YoY Change 195.5% -47.91% -56.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $189.1M $27.50M $0.00
YoY Change 574.85% -100.0%
Total Short-Term Liabilities $268.8M $101.1M $52.25M
YoY Change 414.41% 72.23% -69.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $361.2M $417.9M
YoY Change -100.0% -0.88% 61.28%
Other Long-Term Liabilities $541.0K $1.317M $2.960M
YoY Change -81.72% -55.52% -29.0%
Total Long-Term Liabilities $541.0K $362.5M $420.9M
YoY Change -99.87% -1.32% 59.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $268.8M $101.1M $52.25M
Total Long-Term Liabilities $541.0K $362.5M $420.9M
Total Liabilities $506.4M $648.5M $473.1M
YoY Change 7.03% 50.92% -1.96%
SHAREHOLDERS EQUITY
Retained Earnings -$1.983B -$1.998B -$1.913B
YoY Change 3.67% 10.87% 9.24%
Common Stock $290.0K $228.0K $228.0K
YoY Change 27.19% 16.33% 16.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $89.32M -$156.0M -$104.3M
YoY Change
Total Liabilities & Shareholders Equity $595.7M $492.5M $332.3M
YoY Change 79.25% 74.08% 2.81%

Cashflow Statement

Concept 2016 Q4 2016 Q1 2015 Q4
OPERATING ACTIVITIES
Net Income $35.12M -$59.22M -$41.57M
YoY Change -184.5% 78.14% -28.27%
Depreciation, Depletion And Amortization $200.0K $229.0K $300.0K
YoY Change -33.33% -22.9% -150.0%
Cash From Operating Activities $85.10M $156.8M -$35.40M
YoY Change -340.4% -447.8% -29.2%
INVESTING ACTIVITIES
Capital Expenditures -$600.0K $682.0K -$300.0K
YoY Change 100.0% 2100.0%
Acquisitions
YoY Change
Other Investing Activities -$58.30M -$19.00M $24.30M
YoY Change -339.92% -138.08% -19.54%
Cash From Investing Activities -$58.90M -$19.69M $24.00M
YoY Change -345.42% -139.45% -20.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $37.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.80M -$1.877M 7.400M
YoY Change 113.51% 764.98% 7300.0%
NET CHANGE
Cash From Operating Activities 85.10M $156.8M -35.40M
Cash From Investing Activities -58.90M -$19.69M 24.00M
Cash From Financing Activities 15.80M -$1.877M 7.400M
Net Change In Cash 42.00M $135.2M -4.000M
YoY Change -1150.0% 2845.3% -79.8%
FREE CASH FLOW
Cash From Operating Activities $85.10M $156.8M -$35.40M
Capital Expenditures -$600.0K $682.0K -$300.0K
Free Cash Flow $85.70M $156.1M -$35.10M
YoY Change -344.16% -446.05% -29.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-30
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0000939767
CY2016 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q3 dei Entity Public Float
EntityPublicFloat
1361396920 USD
CY2016 dei Entity Registrant Name
EntityRegistrantName
EXELIXIS, INC.
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
290866613 shares
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2016 dei Trading Symbol
TradingSymbol
exel
CY2015Q4 exel Accrued Clinical Liabilities Current
AccruedClinicalLiabilitiesCurrent
18071000 USD
CY2016Q3 exel Accrued Clinical Liabilities Current
AccruedClinicalLiabilitiesCurrent
18700000 USD
CY2016Q4 exel Accrued Clinical Liabilities Current
AccruedClinicalLiabilitiesCurrent
14131000 USD
CY2015Q4 exel Accrued Collaboration Liability Current
AccruedCollaborationLiabilityCurrent
10938000 USD
CY2016Q4 exel Accrued Collaboration Liability Current
AccruedCollaborationLiabilityCurrent
0 USD
CY2015Q4 exel Cash Cash Equivalentsand Availableforsale Securities
CashCashEquivalentsandAvailableforsaleSecurities
253310000 USD
CY2016Q4 exel Cash Cash Equivalentsand Availableforsale Securities
CashCashEquivalentsandAvailableforsaleSecurities
479554000 USD
CY2015Q4 exel Cash Cash Equivalentsand Availableforsale Securities Amortized Cost Basis
CashCashEquivalentsandAvailableforsaleSecuritiesAmortizedCostBasis
253433000 USD
CY2016Q4 exel Cash Cash Equivalentsand Availableforsale Securities Amortized Cost Basis
CashCashEquivalentsandAvailableforsaleSecuritiesAmortizedCostBasis
479862000 USD
CY2015Q4 exel Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Gain Accumulatedin Investments
CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedGainAccumulatedinInvestments
7000 USD
CY2016Q4 exel Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Gain Accumulatedin Investments
CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedGainAccumulatedinInvestments
14000 USD
CY2015Q4 exel Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Loss Accumulatedin Investments
CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedinInvestments
130000 USD
CY2016Q4 exel Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Loss Accumulatedin Investments
CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedinInvestments
322000 USD
CY2015Q4 exel Collateral Provided For Purchasing Card Program
CollateralProvidedForPurchasingCardProgram
1500000 USD
CY2016Q4 exel Collateral Provided For Purchasing Card Program
CollateralProvidedForPurchasingCardProgram
3000000 USD
CY2016 exel Debt Collateral Number Of Affiliate Banks
DebtCollateralNumberOfAffiliateBanks
1 affiliate
CY2016 exel Debt Collateral Number Of Required Investment Accounts
DebtCollateralNumberOfRequiredInvestmentAccounts
1 account
CY2007Q2 exel Debt Instrument Numberof Instruments
DebtInstrumentNumberofInstruments
2 debt_instrument
CY2016 exel Debt Instrument Numberof Instruments
DebtInstrumentNumberofInstruments
3 debt_instrument
CY2015Q4 exel Deferred Tax Assets Amortization Of Deferred Stock Compensation Non Qualified
DeferredTaxAssetsAmortizationOfDeferredStockCompensationNonQualified
14615000 USD
CY2016Q4 exel Deferred Tax Assets Amortization Of Deferred Stock Compensation Non Qualified
DeferredTaxAssetsAmortizationOfDeferredStockCompensationNonQualified
14780000 USD
CY2015Q4 exel Deferred Tax Assets Book Over Tax Depreciation
DeferredTaxAssetsBookOverTaxDepreciation
1752000 USD
CY2016Q4 exel Deferred Tax Assets Book Over Tax Depreciation
DeferredTaxAssetsBookOverTaxDepreciation
70617000 USD
CY2016Q4 exel Defined Contribution Plan Numberof Shares Availablefor Grant
DefinedContributionPlanNumberofSharesAvailableforGrant
303187 shares
CY2014 exel Effective Income Tax Rate Reconciliation Extinguishmentof Debt Amount
EffectiveIncomeTaxRateReconciliationExtinguishmentofDebtAmount
0 USD
CY2015 exel Effective Income Tax Rate Reconciliation Extinguishmentof Debt Amount
EffectiveIncomeTaxRateReconciliationExtinguishmentofDebtAmount
0 USD
CY2016 exel Effective Income Tax Rate Reconciliation Extinguishmentof Debt Amount
EffectiveIncomeTaxRateReconciliationExtinguishmentofDebtAmount
4726000 USD
CY2014 exel Income Tax Reconciliation Unutilized Net Operating Losses
IncomeTaxReconciliationUnutilizedNetOperatingLosses
84985000 USD
CY2015 exel Income Tax Reconciliation Unutilized Net Operating Losses
IncomeTaxReconciliationUnutilizedNetOperatingLosses
51421000 USD
CY2016 exel Income Tax Reconciliation Unutilized Net Operating Losses
IncomeTaxReconciliationUnutilizedNetOperatingLosses
6377000 USD
CY2014 exel Increase Decrease Accrued Clinical Liabilities
IncreaseDecreaseAccruedClinicalLiabilities
6587000 USD
CY2015 exel Increase Decrease Accrued Clinical Liabilities
IncreaseDecreaseAccruedClinicalLiabilities
-23474000 USD
CY2016 exel Increase Decrease Accrued Clinical Liabilities
IncreaseDecreaseAccruedClinicalLiabilities
-3940000 USD
CY2014 exel Increase Decreasein Accrued Collaboration Liability
IncreaseDecreaseinAccruedCollaborationLiability
732000 USD
CY2015 exel Increase Decreasein Accrued Collaboration Liability
IncreaseDecreaseinAccruedCollaborationLiability
10206000 USD
CY2016 exel Increase Decreasein Accrued Collaboration Liability
IncreaseDecreaseinAccruedCollaborationLiability
-10938000 USD
CY2016Q4 exel Longterm Debt Maturities Repaymentsof Principal After Year Two
LongtermDebtMaturitiesRepaymentsofPrincipalAfterYearTwo
0 USD
CY2016Q4 exel Maximum Potential Milestone Payments
MaximumPotentialMilestonePayments
2200000000 USD
CY2016 exel Numberof Productsin Commercial Market
NumberofProductsinCommercialMarket
3 product
CY2014 exel Paymentsfor Conversionof Convertible Debt
PaymentsforConversionofConvertibleDebt
0 USD
CY2015 exel Paymentsfor Conversionof Convertible Debt
PaymentsforConversionofConvertibleDebt
0 USD
CY2016 exel Paymentsfor Conversionof Convertible Debt
PaymentsforConversionofConvertibleDebt
7135000 USD
CY2016Q4 exel Percentageof Maximum Potential Milestone Payments Clinical Development
PercentageofMaximumPotentialMilestonePaymentsClinicalDevelopment
0.09
CY2016Q4 exel Percentageof Maximum Potential Milestone Payments Commercial
PercentageofMaximumPotentialMilestonePaymentsCommercial
0.49
CY2016Q4 exel Percentageof Maximum Potential Milestone Payments Regulatory
PercentageofMaximumPotentialMilestonePaymentsRegulatory
0.42
CY2014 exel Restructuring Reserve Proceedsfrom Saleof Property Plantand Equipment
RestructuringReserveProceedsfromSaleofPropertyPlantandEquipment
299000 USD
CY2015 exel Restructuring Reserve Proceedsfrom Saleof Property Plantand Equipment
RestructuringReserveProceedsfromSaleofPropertyPlantandEquipment
1325000 USD
CY2016 exel Revenue Recognition Milestone Method Revenue Recognition Percentage
RevenueRecognitionMilestoneMethodRevenueRecognitionPercentage
1
CY2016 exel Sales Revenue Discount Expectedtobe Earned Percent
SalesRevenueDiscountExpectedtobeEarnedPercent
1
CY2016 exel Sales Revenue Percent Discount For Prompt Payment
SalesRevenuePercentDiscountForPromptPayment
0.02
CY2014 exel Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expensed Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpensedFairValue
8600000 USD
CY2015 exel Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expensed Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpensedFairValue
18900000 USD
CY2016 exel Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expensed Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpensedFairValue
13400000 USD
CY2014 exel Unrecognized Tax Benefits Increase Decrease Resultingfrom Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromPriorPeriodTaxPositions
719000 USD
CY2015 exel Unrecognized Tax Benefits Increase Decrease Resultingfrom Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromPriorPeriodTaxPositions
21696000 USD
CY2016 exel Unrecognized Tax Benefits Increase Decrease Resultingfrom Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromPriorPeriodTaxPositions
-29110000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6401000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6565000 USD
CY2015Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3629000 USD
CY2016Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
20334000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24309000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24882000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-232000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-416000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1489727000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1504052000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1591782000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1772123000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2072591000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10006000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21977000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22912000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1470000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10006000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21977000 USD
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22912000 USD
CY2012 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
12442000 USD
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
19722000 USD
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
22289000 USD
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
17041000 USD
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
8432000 USD
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
105664000 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
117478000 shares
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
62458000 shares
CY2015Q4 us-gaap Assets
Assets
332342000 USD
CY2016Q4 us-gaap Assets
Assets
597541000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
178665000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
470803000 USD
CY2015Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
250687000 USD
CY2016Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
459966000 USD
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
250687000 USD
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
459966000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14000 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
130000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
322000 USD
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
250810000 USD
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
460274000 USD
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
172100000 USD
CY2014 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0 USD
CY2015 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0 USD
CY2016 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0 USD
CY2016Q4 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
86 investment
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103978000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80395000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141634000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
151686000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-23583000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
61239000 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10052000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
227960943 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
289923798 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
227960943 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
289923798 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
228000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
290000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-145289000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-237954000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-261564000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-161855000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70406000 USD
CY2014 us-gaap Contracts Revenue
ContractsRevenue
0 USD
CY2015 us-gaap Contracts Revenue
ContractsRevenue
3014000 USD
CY2016 us-gaap Contracts Revenue
ContractsRevenue
56079000 USD
CY2014 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2015 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2016 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
286925000 USD
CY2015Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 USD
CY2016Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
109122000 USD
CY2012Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
291828000 USD
CY2013Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
301550000 USD
CY2014Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
223629000 USD
CY2015Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
337937000 USD
CY2016Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 USD
CY2015Q4 us-gaap Cost Method Investments
CostMethodInvestments
0 USD
CY2016Q4 us-gaap Cost Method Investments
CostMethodInvestments
0 USD
CY2014 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
0 USD
CY2015 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
0 USD
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
2043000 USD
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3895000 USD
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6552000 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-182000 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
55000 USD
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-182000 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
55000 USD
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2016 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
286900000 USD
CY2014 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
2762000 USD
CY2015 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
CY2016 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
19665000 USD
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 USD
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
237094000 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
552996000 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
629314000 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
16669000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
252000 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
464504000 USD
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
471327000 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
106000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
64350000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
64367000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
7775000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
8117000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
536327000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
629062000 USD
CY2016 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
57000000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
16669000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
252000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
497000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
252000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
16172000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1100000 USD
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
400000 USD
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1100000 USD
CY2016 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03
CY2016 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2014 us-gaap Depreciation
Depreciation
2400000 USD
CY2015 us-gaap Depreciation
Depreciation
1400000 USD
CY2016 us-gaap Depreciation
Depreciation
1000000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2391000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1406000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1002000 USD
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.91
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.29
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.34
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.77
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.12
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2014 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
1600000 USD
CY2015 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
11500000 USD
CY2016 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
27500000 USD
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1840000 USD
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
548000 USD
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2014 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
500000 USD
CY2015 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
100000 USD
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-200000 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
600000 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1000000 USD
CY2016 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2014 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
838000 USD
CY2015 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
112000 USD
CY2016 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2494000 USD
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-13900000 USD
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-13901000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
63684000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
63684000 USD
CY2014 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2015 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
8622000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
7306000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
8434000 USD
CY2015Q4 us-gaap Gross Profit
GrossProfit
8915000 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
8414000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
30058000 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
40287000 USD
CY2016Q4 us-gaap Gross Profit
GrossProfit
50064000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-230535000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-150846000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-70222000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-30944000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-10843000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-261479000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-161689000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-70222000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-182000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55000 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-88903000 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-54974000 USD
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-23876000 USD
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
3598000 USD
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
3308000 USD
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2680000 USD
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
255000 USD
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
195000 USD
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
3155000 USD
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
65000 USD
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
50000 USD
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
418000 USD
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-182000 USD
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
55000 USD
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
6520000 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
60000 USD
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
192000 USD
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
190000 USD
CY2014 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
941000 USD
CY2015 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
646000 USD
CY2016 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
37002000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2932000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-12000 USD
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
164000 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1133000 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2582000 USD
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
256759000 USD
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9447000 USD
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
279000 USD
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
16705000 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-509000 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
235000 USD
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
722000 USD
CY2014 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2149000 USD
CY2015 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1340000 USD
CY2016 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1077000 USD
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-5295000 USD
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-10396000 USD
CY2016 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
6774000 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1526000 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
325000 USD
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1610000 USD
CY2014 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-20354000 USD
CY2015 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-19789000 USD
CY2016 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-7150000 USD
CY2012 us-gaap Interest Expense
InterestExpense
24778000 USD
CY2013 us-gaap Interest Expense
InterestExpense
38779000 USD
CY2014 us-gaap Interest Expense
InterestExpense
41362000 USD
CY2015 us-gaap Interest Expense
InterestExpense
40680000 USD
CY2016 us-gaap Interest Expense
InterestExpense
33060000 USD
CY2014 us-gaap Interest Paid
InterestPaid
19109000 USD
CY2015 us-gaap Interest Paid
InterestPaid
19822000 USD
CY2016 us-gaap Interest Paid
InterestPaid
21044000 USD
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
583000 USD
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
738000 USD
CY2015Q4 us-gaap Inventory Gross
InventoryGross
3871000 USD
CY2016Q4 us-gaap Inventory Gross
InventoryGross
3944000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
2616000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
3338000 USD
CY2015Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
1255000 USD
CY2016Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
606000 USD
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1037000 USD
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
863000 USD
CY2015Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2251000 USD
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2343000 USD
CY2015 us-gaap Inventory Write Down
InventoryWriteDown
1200000 USD
CY2016 us-gaap Inventory Write Down
InventoryWriteDown
500000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
476015000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
483452000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
482592000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
473148000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
508223000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
332342000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
597541000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52251000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
270588000 USD
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
417937000 USD
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
189122000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
189122000 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
80000000 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
124972000 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
417937000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2015Q4 us-gaap Long Term Investments
LongTermInvestments
83600000 USD
CY2016Q4 us-gaap Long Term Investments
LongTermInvestments
55601000 USD
CY2015Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
80000000 USD
CY2016Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
65492000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
152747000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19804000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
146330000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
50077000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-216048000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-235405000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-141585000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
206296000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-145335000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-238192000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-261297000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-33245000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-41389000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-45542000 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-41568000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-161744000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-59223000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-34838000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-11284000 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
35123000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-70222000 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22792000 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37556000 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37021000 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-40268000 USD
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-42098000 USD
CY2015Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2016Q4 us-gaap Notes Payable Current
NotesPayableCurrent
80000000 USD
CY2016 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1000 segment
CY2014 us-gaap Operating Expenses
OperatingExpenses
249569000 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
158593000 USD
CY2016 us-gaap Operating Expenses
OperatingExpenses
219578000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-224458000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-22760000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-31280000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-35781000 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-31600000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-121421000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-49135000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-25136000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7264000 USD
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
38883000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-28124000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
11481000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
8474000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
1200000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3007000 USD
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
10300000 USD
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
8700000 USD
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
6100000 USD
CY2014 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
4900000 USD
CY2015 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
5200000 USD
CY2016 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
3600000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13212000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20771000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2309000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1232000 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-267000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-111000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-184000 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2014 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2015 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2016 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 USD
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-267000 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-111000 USD
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-184000 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4341000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
412000 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4863000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2960000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
541000 USD
CY2014 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4161000 USD
CY2015 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1327000 USD
CY2016 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2510000 USD
CY2014 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0 USD
CY2015 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0 USD
CY2016 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0 USD
CY2014 us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
CY2015 us-gaap Paid In Kind Interest
PaidInKindInterest
3817000 USD
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
8008000 USD
CY2014 us-gaap Payments For Restructuring
PaymentsForRestructuring
10236000 USD
CY2015 us-gaap Payments For Restructuring
PaymentsForRestructuring
8827000 USD
CY2016 us-gaap Payments For Restructuring
PaymentsForRestructuring
4573000 USD
CY2014 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
119528000 USD
CY2015 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
143992000 USD
CY2016 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
369187000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
474000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
447000 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1703000 USD
CY2014 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
8143000 USD
CY2015 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
5650000 USD
CY2016 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
8650000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3806000 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5416000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
75600000 USD
CY2015Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
145600000 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
75643000 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
145649000 USD
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2014 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
252891000 USD
CY2015 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
178936000 USD
CY2016 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
151485000 USD
CY2014 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-11709000 USD
CY2015 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-4381000 USD
CY2016 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 USD
CY2014 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
838000 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
95000 USD
CY2016 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
2494000 USD
CY2014 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
CY2015 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
CY2016 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
2266000 USD
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
392000 USD
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1346000 USD
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
97000 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
120000 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10911000 USD
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25327000 USD
CY2014 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1438000 USD
CY2015 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
568000 USD
CY2016 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2187000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25743000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26953000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1434000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2071000 USD
CY2015Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
5183000 USD
CY2016Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
42246000 USD
CY2014 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2015 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2016 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
575000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
189101000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
96351000 USD
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
95967000 USD
CY2015Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
2650000 USD
CY2016Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
4150000 USD
us-gaap Restructuring Charges
RestructuringCharges
62834000 USD
CY2014 us-gaap Restructuring Charges
RestructuringCharges
7596000 USD
CY2015 us-gaap Restructuring Charges
RestructuringCharges
1042000 USD
CY2016 us-gaap Restructuring Charges
RestructuringCharges
914000 USD
CY2013Q4 us-gaap Restructuring Reserve
RestructuringReserve
13472000 USD
CY2014Q4 us-gaap Restructuring Reserve
RestructuringReserve
10791000 USD
CY2015Q4 us-gaap Restructuring Reserve
RestructuringReserve
4590000 USD
CY2016Q4 us-gaap Restructuring Reserve
RestructuringReserve
1940000 USD
CY2014 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-340000 USD
CY2015 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
259000 USD
CY2016 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
1009000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1251692000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1489884000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1751181000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1912925000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1983147000 USD
CY2014 us-gaap Revenues
Revenues
25111000 USD
CY2015Q1 us-gaap Revenues
Revenues
9388000 USD
CY2015Q2 us-gaap Revenues
Revenues
7992000 USD
CY2015Q3 us-gaap Revenues
Revenues
9854000 USD
CY2015Q4 us-gaap Revenues
Revenues
9938000 USD
CY2015 us-gaap Revenues
Revenues
37172000 USD
CY2016Q1 us-gaap Revenues
Revenues
15427000 USD
CY2016Q2 us-gaap Revenues
Revenues
36252000 USD
CY2016Q3 us-gaap Revenues
Revenues
62194000 USD
CY2016Q4 us-gaap Revenues
Revenues
77581000 USD
CY2016 us-gaap Revenues
Revenues
191454000 USD
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
25111000 USD
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
34158000 USD
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
135375000 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
50829000 USD
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57305000 USD
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
116145000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
10006000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
21977000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
22912000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
0.5
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
17731361 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.01
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
80516 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
307601 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4200950 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
250996000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27425854 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
24999665 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.22
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.91
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.07
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.49
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.67
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.29
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
17731361 shares
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
24999665 shares
CY2014Q1 us-gaap Share Price
SharePrice
8.00
CY2015Q3 us-gaap Share Price
SharePrice
5.40
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
193288000 USD
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y11M23D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y6M14D
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
4.01
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
4.91
CY2016 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y6M14D
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
25426000 USD
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
268117000 USD
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10000000 shares
CY2015Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
28750000 shares
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6239022 shares
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
253080000 USD
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
75643000 USD
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
145649000 USD
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2093000 USD
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11277000 USD
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
24538000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
238127000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14498000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-159324000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-140806000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
89318000 USD
CY2014 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
700000 USD
CY2015 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
CY2016 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
55077000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
58215000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
88638000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
61809000 USD
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2706000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
8727000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2304000 USD
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
287000 USD
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2016 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
23000 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
88800000 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
7900000 USD
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
92700000 USD
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
194299000 shares
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
209227000 shares
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
250531000 shares
CY2016 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts in the Consolidated Financial Statements have been reclassified to conform to current period presentation. </font></div></div>
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of our consolidated financial statements is in conformity with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. </font><font style="font-family:inherit;font-size:10pt;">On an ongoing basis, management evaluates its estimates including, but not limited to, those related to revenue recognition, including deductions from revenues (such as rebates, chargebacks, sales returns and sales allowances), the period of performance, identification of deliverables and evaluation of milestones with respect to our collaborations, the amounts of revenues and expenses under our profit and loss sharing agreement, recoverability of inventory, certain accrued liabilities including the accrued clinical trial liability, the valuation of the debt and equity components of our convertible debt and stock-based compensation. </font><font style="font-family:inherit;font-size:10pt;">We base our estimates on historical experience and on various other market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div></div>

Files In Submission

Name View Source Status
R30.htm Edgar Link pending
0000939767-17-000019-index-headers.html Edgar Link pending
0000939767-17-000019-index.html Edgar Link pending
0000939767-17-000019.txt Edgar Link pending
0000939767-17-000019-xbrl.zip Edgar Link pending
exel-20161230.xml Edgar Link completed
exel-20161230.xsd Edgar Link pending
exel-20161230_cal.xml Edgar Link unprocessable
exel-20161230_def.xml Edgar Link unprocessable
exel-20161230_lab.xml Edgar Link unprocessable
exel-20161230_pre.xml Edgar Link unprocessable
exel2016123110-k.htm Edgar Link pending
exel20161231exhibit1017.htm Edgar Link pending
exel20161231exhibit1026.htm Edgar Link pending
exel20161231exhibit1029.htm Edgar Link pending
exel20161231exhibit1045.htm Edgar Link pending
exel20161231exhibit1046.htm Edgar Link pending
exel20161231exhibit1047.htm Edgar Link pending
exel20161231exhibit1049.htm Edgar Link pending
exel20161231exhibit1051.htm Edgar Link pending
exel20161231exhibit1052.htm Edgar Link pending
exel20161231exhibit121.htm Edgar Link pending
exel20161231exhibit211.htm Edgar Link pending
exel20161231exhibit231.htm Edgar Link pending
exel20161231exhibit311.htm Edgar Link pending
exel20161231exhibit312.htm Edgar Link pending
exel20161231exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fiveyearchart2016.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending